Company profile

Avrion Therapeutics AG

More news about Avrion Therapeutics AG

14.10.2021 14:00

Alpine Techstars to attract investors

Support

14.07.2021 17:02

The first cohort for the Venture Leaders Biotech roadshow revealed

Award

01.04.2021 13:27

Les meilleures startups suisses de Bilan révélées

Financing

Support

18.01.2021 09:51

Life science start-ups attract experienced board members

Expansion

14.09.2020 08:32

Strong Swiss delegation at Bio Europe

Background

Support

Avrion Therapeutics AG

Founded
2020

Kanton
Basel-Landschaft

Twitter
@Avriontx

Principal

Innosuisse

Swiss Venture Capital Report

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.

Register for more services

Partners

Gebert Rüf Stiftung

Swiss Entrepreneurs Foundation

UBS

Contributors

EPFL Innovation Park Foundation

IFJ

Innovaud

Kendris

Lichtsteiner Foundation

SICTIC

Startup Campus

Swiss Economic Forum

Swisscom

Swissnex

Switzerland Innovation

venturelab

W.A. De Vigier Stiftung

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

ESA BIC Switzerland

StartAngels Network

Switzerland Global Enterprise

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

EPFL Innovation Park Foundation

ESA BIC Switzerland

Gebert Rüf Stiftung

StartAngels Network

Swiss Entrepreneurs Foundation

Switzerland Global Enterprise

Switzerland Innovation

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

W.A. De Vigier Stiftung

By continuing to use this website you agree with our TERMS AND CONDITIONS